Faculty, Staff and Student Publications

Publication Date

5-1-2025

Journal

American Journal of Respiratory and Critical Care Medicine

Abstract

Patients with idiopathic pulmonary fibrosis and lung fibrosis secondary to infections such as influenza A and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have limited treatment options outside of supportive therapy and lung transplantation. Multiple lung stem cell populations have been implicated in the pathogenesis of lung fibrosis, and more progenitor cell populations continue to be discovered and characterized. In this review, we summarize the functions and differentiation pathways of various cells that constitute the lung epithelium. We then focus on two subpopulations of KRT5

Keywords

Humans, Animals, Idiopathic Pulmonary Fibrosis, Lung, Pulmonary Fibrosis, Cell Differentiation, COVID-19, Stem Cells, Alveolar Epithelial Cells, Epithelium, SARS-CoV-2

DOI

10.1165/rcmb.2024-0372TR

PMID

39642382

PMCID

PMC12051923

PubMedCentral® Posted Date

12-6-2024

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.